 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
|
Articles 
Brian J. McMahon, Thomas W. Hennessy, J. Michael Bensler, Dana L. Bruden, Alan J. Parkinson, Julie M. Morris, Alisa L. Reasonover, Debby A. Hurlburt, Michael G. Bruce, Frank Sacco, and Jay C. Butler Use of macrolide antibiotics is associated with increased risk that subsequent infection with Helicobacter pylori will be clarithromycin resistant and that clarithromycin treatment will fail.
Marco Ruggeri, Alberto Tosetto, Maurizio Frezzato, and Francesco Rodeghiero The prevalences of polycythemia vera and essential thrombocythemia in a general population were higher than expected. However, the risks for developing polycythemia vera, essential thrombocythemia, or associated vascular complications in persons with erythrocytosis or thrombocytosis were low.
Mariette W.C.J. Schoofs, Marjolein van der Klift, Albert Hofman, Chris E.D.H. de Laet, Ron M.C. Herings, Theo Stijnen, Huibert A.P. Pols, and Bruno H.Ch. Stricker Thiazide diuretics protect against hip fracture in persons 55 years of age and older. This effect disappears within 4 months after stopping thiazides.
Brief Communications
Maria Sjölund, Karin Wreiber, Dan I. Andersson, Martin J. Blaser, and Lars Engstrand A common Helicobacter pylori regimen (clarithromycin, metronidazole, and omeprazole) selects for highly resistant enterococci that can persist in the gastrointestinal tract for at least 3 years.
Masayuki Adachi, Hidetsugu Saito, Hisashi Kobayashi, Yoshinori Horie, Shinzo Kato, Masahiro Yoshioka, and Hiromasa Ishii The weight loss aids Chaso and Onshido may be associated with acute liver injury. These products contain N-nitroso-fenfluramine, a possibly hepatotoxic compound.
Academia and Clinic
Richard N. Shiffman, Paul Shekelle, J Marc Overhage, Jean Slutsky, Jeremy Grimshaw, and Aniruddha M. Deshpande The Conference on Guideline Standardization (COGS) convened to define recommendations on how to report a practice guideline. The proposed standard is a list of information that would help a potential guideline user to decide whether the guideline recommendations were valid and usable.
Reviews
Cornelia M. Weyand and Jörg J. Goronzy This review discusses the pathogenesis, diagnosis, and treatment of giant-cell arteritis and polymyalgia rheumatica.
Frank A. Lederle Ultrasonographic screening and elective repair have substantially reduced mortality from abdominal aortic aneurysms (AAAs). One-time ultrasonographic screening and elective repair when the AAA is 5.5 cm in diameter or larger is reasonable practice for 65- to 79-year-old men who have ever smoked.
Editorials
Louis B. Rice We are seldom able to treat an infecting bacterium without also doing significant "collateral damage" to our friendly microflora. The papers by McMahon and Sjölund and colleagues in this issue present 2 examples of collateral damage associated with the use of antimicrobial agents.
On Being a Doctor
Kevan Pickrel Many of our work experiences we smooth and shape in the retelling like pebbles being polished by the tides. Some are more valuable for their sharp edges and the pain and lesson they bring by holding them tight.
Letters Deferred Care for Emergency Department Users with Nonacute Conditions
Pneumonitis with Antiandrogens
Management of Acute Renal Failure
Screening for Prostate Cancer
Iron Overload Related to Excessive Vitamin C Intake
Correction: Next-Day Care for Emergency Department Users with Nonacute Conditions
Brent A. Bauer
David Weinberg
Jennifer Fisher Wilson
Jeanne Wallace This Update describes recent advances in treating pulmonary hypertension and outlines the issues surrounding proposals to screen for lung cancer by using low-dose computed tomography. | |||||||||||||||||||||||||||||||||||||||||||||||||||
In this Issue
Articles
Previous Issue